French Observatory of Familial Hypercholesterolemia in Cardiology

• Register: ClinicalTrials.gov
• Last refreshed on: 12 December 2020
• Main ID: NCT02013713
• Date of registration: 06/12/2013
• Prospective Registration: Yes
• Primary sponsor: French Cardiology Society
• Public title: French Observatory of Familial Hypercholesterolemia in Cardiology FH Care
• Scientific title: French Observatory of Familial Hypercholesterolemia in Cardiology
• Date of first enrolment: November 2014
• Target sample size: 31
• Recruitment status: Terminated
• URL: https://clinicaltrials.gov/show/NCT02013713
• Study type: Observational

Countries of recruitment

France

Key inclusion & exclusion criteria

Inclusion Criteria:

- coronary patients

- who agreed to participate

- high LDL-c levels: * LDL-c> = 1.9g / l without lipid lowering treatment according to
the diagnostic score of Family Hypercholesterolemia these coronary patients with LDL>
1.9g / l may possibly or probably be achieved Hypercholesterolemia Family.

or

* LDL-c> = 1.6g / l in lipid-lowering treatment, the reduction of LDL-c average expected
under standard lipid-lowering therapy (statin alone) being 30-40% of these patients had
therefore pretreatment levels greater than 2 g / l or greater than 2.5 g / l and may
possibly or probably be achieved Family Hypercholesterolemia after the diagnostic score.

Exclusion Criteria:

- Expressed refusal to participate in the observatory

- Age = 18



Age minimum: 18 Years
Age maximum: N/A
Gender: All

Health Condition(s) or Problem(s) studied

Familial Hypercholesterolemia

Primary Outcome(s)

Frequency of the Family Hypercholesterolemia in cardiology [Time Frame: 1 day]

Secondary ID(s)

12 449

Source(s) of Monetary Support

Please refer to primary and secondary sponsors